Avon Products, Inc. , the leading manufacturer and marketer of beauty and related products, reported first-quarter 2018 results. The company posted adjusted loss per share of 2 cents that came in line with the Zacks Consensus Estimate. Further, the company recorded a loss of 7 cents per share in the year-ago quarter.

Earnings Estimate Revision: The Zacks Consensus Estimate for 2018 has been stable in the last 30 days. However, if we look at Avon’s performance in the trailing four quarters (excluding the quarter under review), the company has underperformed the earnings estimates by an average of 35.7%.

Avon Products, Inc. Price, Consensus and EPS Surprise

Avon Products, Inc. Price, Consensus and EPS Surprise | Avon Products, Inc. Quote

Revenues: Avon’s total revenues of $1,393.5 million grew 5% from the year-ago quarter’s figure and also surpassed the Zacks Consensus Estimate of $1,365 million. Further, on a constant dollar basis, revenues rose 2%.

Zacks Rank: Currently, Avon Products carries a Zacks Rank #3 (Hold), which is subject to change following the earnings announcement. You can seethe complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Check back later for our full write up on Avon Products’ earnings report!

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>